SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending as Warner Bros. Discovery evaluates a revised, higher bid from Paramount Skydance, driving fervent community discussion on whether Netflix should match the offer or walk away, with many believing the latter would lead to a significant stock rally by avoiding the acquisition.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal Holdings is trending following reports of potential acquisition interest from Stripe, sparking widespread community discussion about a possible bidding war for the deeply undervalued payments giant. Investors are actively debating various buyout scenarios, recognizing PayPal's extensive user base and robust cash generation capabilities.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is trending after reporting strong earnings, achieving positive GAAP net income, and raising future guidance, highlighting consistent growth and strategic AI integration. Despite this positive news, the community reflects frustration as the stock's immediate market reaction appears impacted by broader software sector pressures and AI-related concerns, obscuring its fundamental strengths and proprietary data moat.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is a top trending stock as its latest earnings results and outlook have fueled significant investor frustration and concerns over continued share dilution needed to fund upcoming vehicle platforms. The community is actively debating the company's persistent cash burn and leadership uncertainty, leading to a largely pessimistic sentiment for the luxury EV manufacturer amidst a challenging sector.

Workday, Inc. engages in the provision of development of enterprise cloud applications for finance and human resources. It delivers financial management, human capital management and analytics applications designed for companies, educational institutions, and government agencies. The company was founded by David A. Duffield and Aneel Bhusri in 2005 and is headquartered in Pleasanton, CA.

Workday Inc - Ordinary Shares - Class A

Workday Inc

Workday Inc is trending as its latest earnings, which beat estimates, were met with a significant sell-off after the company issued a lower-than-anticipated subscription revenue forecast, intensifying community debate over AI's potential disruption to the software sector and future growth.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is trending following robust preliminary Q4 and full-year 2025 results showcasing substantial revenue growth and record total contract value, which is fueling bullish analyst upgrades and reported institutional buying. Despite mixed market reactions and discussions around profitability, many in the community are actively buying dips amidst high short interest in the AI-driven healthcare platform.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is trending following its recent financial results that surpassed revenue expectations and offered optimistic guidance, fueling discussions around its advanced GaN and SiC power platforms crucial for next-gen AI data centers. The community is actively weighing the immense potential of its technology and perceived positioning within the NVIDIA ecosystem against persistent concerns regarding a lack of definitive, revenue-generating contracts.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVA is trending following its Q4 earnings report, which highlighted robust revenue and expansion plans, sparking community debate over profitability challenges and whether its high valuation is justified amidst mixed performance metrics.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

Axon Enterprise is generating significant conversation following a strong Q4 earnings report and ambitious long-term revenue targets, with the community enthusiastically discussing its growth and potential impact from increasing body camera mandates, even as some debate its high valuation and recent market performance.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros Discovery is trending as its board evaluates a revised offer from Paramount Skydance, which could be deemed a superior proposal, intensifying the bidding war and prompting community debate on whether Netflix will match or if regulatory hurdles will impact the high-stakes media acquisition.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The deal includes an initial five-year term and may automatically renew for another five years if performance targets are met.</li><li>The licensing agreement is expected to deliver immediate scale and revenue as soon as it goes into effect.&nbsp;</li><li>The expanded portfolio is expected to strengthen Tilray’s distributor relationships and broaden national chain offerings.</li></ul>Tilray Brands, Inc. (TLRY) on Wednesday announced that it has secured exclusive rights to brew, market, and distribute several Carlsberg beer brands across the U.S. beginning in 2027.Tilray is a diversified global consumer goods company and the fourth-largest craft beer brewer in the U.S.<h2 class="st-heading-2">Expanding U.S. Beer Presence</h2>The multi-year licensing agreement with the Danish brewing giant will allow Tilray to produce and distribute Carlsberg, Carlsberg Elephant, 1664, and Kronenbourg 1664 Blanc beers in all U.S. channels starting Jan. 1, 2027.&nbsp;The deal includes an initial five-year term and may automatically renew for another five years if performance targets are met. Tilray will use its brewing facilities, sales teams, and commercial networks to locally make and grow the market reach of these imported beers.&nbsp;Following the announcement,&nbsp;<a href="https://stocktwits.com/symbol/TLRY">Tilray Brands’ stock&nbsp;</a>traded over 4% higher by Wednesday mid-morning.&nbsp;<h2 class="st-heading-2">Strategic Benefits For Tilray</h2>The licensing agreement is expected to deliver immediate scale and revenue as soon as it goes into effect.&nbsp;<blockquote>“By combining Carlsberg’s iconic global brands and proven brewing heritage with Tilray Beverages’ U.S. operational scale, quality standards, and national commercial team, we are well positioned to expand Carlsberg’s presence in the premium European segment and drive long-term growth in the U.S. beer market.”-Irwin D. Simon, Chairman and CEO, Tilray</blockquote>This expanded portfolio may help strengthen Tilray’s distributor relationships, broaden national chain offerings, and enhance its standing in the U.S. beverage category.<h2 class="st-heading-2">How Did Stocktwits Users React?&nbsp;</h2>On Stocktwits, retail sentiment around the stock jumped to ‘bullish’ from ‘bearish’ territory the previous day. Message volume changed to ‘high’ from ‘low’ levels in 24 hours.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_02_18_112750_png_7df23c56bf.webp" alt="TLRY’s Sentiment Meter and Message Volume as of 11:20 a.m. ET on Feb. 18, 2026 | Source: Stocktwits" width="935" height="110"><figcaption>TLRY’s Sentiment Meter and Message Volume as of 11:20 a.m. ET on Feb. 18, 2026 | Source: Stocktwits</figcaption></figure>A bullish Stocktwits user lauded the partnership.<stembedurl>https://stocktwits.com/Alexsolstice/message/645225129</stembedurl>&nbsp;TLRY stock has declined by over 12% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/moderna-stock-fda-accepts-revised-flu-vaccine-application-for-review/cZR0MwoR4v1">Moderna Stock Gains After FDA Accepts Company’s Revised Flu Vaccine Application For Review</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a Tilray Brands logo is seen displayed on a smartphone and in the background.

Tilray To Produce And Distribute Carlsberg Beer Brands In US – Stock Gains 4%

The multi-year licensing agreement with the Danish brewing giant will allow Tilray to produce and distribute several Carlsberg beer brands in all U.S. channels starting Jan. 1, 2027. 

Equity

The multi-year licensing agreement with the Danish brewing giant will allow Tilray to produce and distribute several Carlsberg beer brands in all U.S. channels starting Jan. 1, 2027. 


<ul class="summary-bullets"><li>Tilray’s Q2 revenue rose 3% to $217.5 million, beating estimates of $211.5 million, according to Fiscal.ai data</li><li>The management reaffirmed its fiscal 2026 adjusted EBITDA outlook of $62 million to $72 million.</li><li>Tilray is currently operating at an annualized run rate of about $150 million, CEO Irwin D. Simon told analysts on a call on Thursday.</li></ul>Tilray Brands (TLRY) stock gave up most of its early gains to trade about 2.5% higher on Friday after Alliance Global slashed its price target on the stock, pointing to limited visibility into the company’s long-term sales trajectory and cash flow following its second-quarter (Q2) fiscal 2026 results.Analyst Aaron Grey reduced Tilray’s target price to $10 from $20 while maintaining a ‘Neutral’ rating. He said the quarter came in largely in line at the consolidated level, with “some strengths offsetting some weaknesses,” but the firm stayed on the sidelines, looking for clearer insight into the company’s sales and cash flow outlook.<h2 class="st-heading-2">Q2 Print</h2>Tilray’s second-quarter (Q2) revenue rose 3% to $217.5 million, beating estimates of $211.5 million, according to Fiscal.ai data. The revenue increase was driven by a 36% jump in international medical cannabis sales. Net loss narrowed to $43.5 million from $85.3 million a year earlier.Operating cash flow remained negative, though it narrowed to $8.5 million compared to $40.7 million last year. The firm’s management reaffirmed its fiscal 2026 adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) outlook of $62 million to $72 million, citing long-term opportunities tied to U.S. cannabis rescheduling and medical expansion.Chairman and CEO Irwin D. Simon told analysts on a call on Thursday that Tilray is currently operating at an annualized run rate of about $150 million, driven mainly by international markets. Simon also added that Europe, particularly Germany, the U.K., and Poland, represents a significant growth opportunity.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Despite the intraday gains, retail sentiment on Stocktwits for <a href="https://stocktwits.com/symbol/TLRY">TLRY</a> remained in the ‘bearish’ territory over the past 24 hours.<figure class="image"><img src="https://news.stocktwits-cdn.com/TLRY_jpg_463814541d.webp" alt="TLRY.jpg" width="922" height="96"><figcaption>&nbsp;</figcaption></figure>However, some users were bullish, with one highlighting Tilray’s strong results.<stembedurl>https://stocktwits.com/Mlitton13/message/641317326</stembedurl>The stock has declined 24% over the past year.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-oklo-stock-surged-premarket-today-meta-deal/cmU2fX3R4dI">OKLO Stock Surged 20% In Premarket Today – What’s The Meta Agreement About?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

TLRY Stock In Focus After Alliance Global Halves Price Target

Alliance Global cut TLRY’s target price to $10 from $20, citing limited visibility into the company’s long-term sales trajectory and cash flow.

Cannabis ETFs Soar Double-Digits on Friday: Here's Why

Cannabis ETFs explode on reform buzz. CNBS, WEED, MSOS and MJ jumped double-digits on Dec. 12, 2025 as Trump reportedly weighs reclassifying marijuana, boosting optimism.

The Zacks Analyst Blog Highlights MSOS, CNBS, WEED, MJ and YOLO

Zacks Analyst Blog highlights MSOS, CNBS, WEED, MJ, and YOLO as marijuana ETFs soar over 100% in three months on U.S. legalization hopes and investor optimism.

From Loss to Lift-Off: Marijuana ETFs Rebound on Legalization Prospects 

Marijuana ETFs, such as WEED, MSOS, and CNBS, are rebounding as hopes for rescheduling boost investor optimism. 

Cannabis ETFs Soar as Trump Mulls Over Marijuana Reclassification

Cannabis ETFs like WEED, CNBS and MJ surge after Trump confirmed that his administration is weighing marijuana's move from Schedule I to Schedule III.


Nasdaq-listed shares of Canopy Growth Corp. (CGC) fell 12% in pre-market trading on Friday after the cannabis company <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.canopygrowth.com/investors/news-releases/canopy-growth-reports-fourth-quarter-and-fiscal-year-2025-financial-results/">reported</a> wider-than-expected fourth-quarter (Q4) loss.The company’s fourth quarter revenue fell 11% year-on-year (YoY) to C$65.03 million ($47.16 million), below an analyst estimate of C$70.87 million, according to Finchat data.The company attributed the drop to a decline in net revenue from its international markets cannabis, and Storz &amp; Bickel segments.In Canada, cannabis net revenue was C$40 million in the quarter, marking an increase of 4% YoY. However, across international markets, the revenue declined 35% YoY to C$8 million, owing to a decline in medical cannabis sales in Poland and Australia, the company said.Storz and Bickel, meanwhile, delivered net revenue of C$17 million in the quarter, a decrease of 23% YoY, owing to softer consumer demand for its devices. Storz and Bickel designs vaporizers for combustion-free vaporization and inhalation of dry herbs.The company’s gross margin fell by 500 basis points to 16% in the quarter, and it reported an adjusted loss before interest, taxes, depreciation, and amortisation (EBITDA) of C$9 million. Analysts had only expected a loss of C$3.13 million.The company’s total debt, however, decreased to C$304 million as of March 31, compared to C$597 million on the corresponding date of 2024.The company said on Friday that it plans to continue to focus on accelerating growth in global medical cannabis, improving commercial execution, and profitability in Canada’s adult-use cannabis market. The company also said that cost actions are underway and it expects annualized savings of at least C$20 million over the next 12 to 18 months.CFO Judy Hong also said that the company is committed to achieving positive adjusted EBITDA in the “near-term,” without specifying a timeline.On Stocktwits, retail sentiment around Canopy Growth stayed within the ‘bearish’ territory over the past 24 hours while message volume rose from ‘normal’ to ‘high’ levels.<figure class="image"><img style="aspect-ratio:627/64;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_30_at_8_59_37_AM_png_cf8cb9e0cf.webp" alt="CGC's Sentiment Meter and Message Volume as of 8:15 a.m. ET on May 30, 2025 | Source: Stocktwits" width="627" height="64"><figcaption>CGC's Sentiment Meter and Message Volume as of 8:15 a.m. ET on May 30, 2025 | Source: Stocktwits</figcaption></figure> A Stocktwits user termed the Q4 earnings reports “a pretty big let down.” &nbsp;<stembedurl>https://stocktwits.com/JustAGlitchBTMFD/message/616291899</stembedurl><a href="https://stocktwits.com/symbol/CGC">CGC stock </a>is down by about 41% this year and by about 80% over the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/zymeworks-drug-gets-conditional-approval-for-biliary-tract-cancer-in-china/ch0Mun4RbMx">Zymeworks’ Drug Gets Conditional Approval For Biliary Tract Cancer Treatment In China: Retail Sentiment Refuses To Budge</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.(Exchange Rate: I Canadian Dollar= 0.73 US Dollar)

A cart full of bagged marijuana is rolled through the corridors at the Canopy Growth Corporation headquarters in Smiths Falls, Ontario, on May 15, 2019. (Photo by Lane Turner/The Boston Globe via Getty Images)

Canopy Growth Stock Drops Pre-Market After Disappointing Q4 Earnings: Retail Terms It ‘A Pretty Big Let Down’

CFO Judy Hong said the company is committed to achieving positive adjusted EBITDA in the “near-term,” without specifying a timeline.

Smiths Falls, Ontario-hased&nbsp;Canopy Growth Corp. ($CGC), which has under-delivered relative to expectations in the past few quarters, is scheduled to report its fiscal year 2025 second quarter-results before the market opens on Friday.&nbsp;Analysts, on average, expect the cannabis company to report a quarterly loss of $0.36 per share, narrower than the year-ago loss of $1.15 per share. The consensus revenue estimate is at $46.8 million, down from $53.51 million reported for the second quarter of last fiscal.&nbsp;In the first quarter that ended on June 30, 2024, the company reported revenue of $66.2 million, with roughly 57% coming from the Canadian market. About 15% came from international operations and the remainder from the vaporizer brand Storz &amp; Bickel. The Canadian operation drew equal share of revenue from adult-use cannabis and medical cannabis.Following the second-quarter earnings release, CEO David Klein, who is set to retire by the March quarter, and CFO Judy Hong will host an audio webcast at 10 am ET.In mid-October, the company said it made early prepayment of $100 million worth of senior secured term loan at a discounted price of $97.5 million. This will result in annualized interest expense savings of $14 million, it added.Canopy Growth’s U.S. unit completed the acquisition of Wana during the quarter. With the Wana buy and the purchase of a 75% stake in Jetty, a California-based producer of cannabis extracts and clean vape, the company is looking to solidify its U.S. business.It remains unclear how the incoming Trump administration will regulate the cannabis industry in the U.S. As recently as this week, Florida voted against legalizing recreational marijuana by adults, as the amendment for the same did not achieve the 60% supermajority threshold to pass.&nbsp;During his campaign, Trump said he would support reclassifying marijuana as a Schedule 3 drug, thereby easing federal restrictions on pot.In premarket trading, as of 4:33 am ET, Canopy Growth stock was up 1.10% at $4.60.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/paramount-to-report-q3-results-as-sky-dance-merger-looms-retail-shrugs-off-stock-woes/cJ4EyfkRam">Paramount To Report Q3 Results As SkyDance Merger Looms, Retail Shrugs Off Stock Woes</a>For updates and corrections email newsroom@stocktwits.com&nbsp;

Canopy Growth is looking to turn things around following bottom-line misses in recent quarters.

Canopy Growth Stock Rises Ahead Of Q2 Report As Pot Producers Await  Clarity On Trump’s Policy

Canopy Growth is looking to solidify its U.S. business, thanks to its two acquisitions in the country this year.

Cannabis firm Canopy Growth Corporation was among the top trending stocks on Stocktwits on Friday after the company failed to meet first-quarter earnings estimates.The company reported an earnings loss of C$1.63 compared to an estimated loss of C$0.46 while revenue came in 13% lower on a year-over-year (YoY) basis at C$66.21 million versus an estimate of C$70.1 million.The firm’s net loss widened to C$127.14 million during the quarter compared to a net loss of C$38.12 million in the same quarter a year ago.On the positive side, the company said it has entered into an amendment to its credit agreement with all of the lenders to its senior secured term loan. According to the new agreement, the firm will see significant deleveraging of up to US$200 million.Following the announcement, retail sentiment continued to trend in the ‘bullish territory’ (61/100) although the score inched-down a bit compared to Thursday.<figure class="image"><a href="https://stocktwits.com/symbol/CGC"><img style="aspect-ratio:1888/530;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_08_09_at_9_33_52_AM_c532f1dba8.png" alt="Canopy Growth sentiment meter as of 9:09 a.m. EST on August 09, 2024" width="1888" height="530"></a><figcaption>Canopy Growth sentiment meter as of 9:09 a.m. EST on August 09, 2024</figcaption></figure>Judy Hong, Chief Financial Officer of Canopy Growth Corporation said the firm’s strategic initiatives have led to notable improvements in gross margins and adjusted operating profit as well as reduction in selling, general and administrative (SG&amp;A) expenses. “We are pleased that all of our business units delivered positive Adjusted EBITDA during Q1 Fiscal 2025 and expect to achieve positive Adjusted EBITDA on a consolidated basis in the second half of the fiscal year,” Hong said.On a segmental basis, Canada cannabis net revenue came in at C$38MM in Q1FY2025, registering a decrease of 6% YoY. At the same time, international markets cannabis net revenue declined 1%.The firm also posted a deal update with Canopy USA closing the acquisitions of approximately 75% of the shares of Lemurian, Inc. and two of three Wana entities — Wana Wellness, LLC and The CIMA Group.Stocktwits users are expressing optimism after the earnings announcement and are bullish on the firm’s prospects following the balance sheet restructuring.<stembedurl>https://stocktwits.com/KLONDIKER/message/582426681</stembedurl>Additionally, comments from Republican presidential nominee Donald Trump on Monday suggested a looser policy stance toward Cannabis could be coming, which helped buoy sentiment toward the overall sector.

reported an earnings loss of C$1.63 compared to an estimated loss of C$0.46

Why This Cannabis Firm Is Among The Top Trending On Stocktwits Today

The firm’s net loss widened to C$127.14 million during the quarter compared to a net loss of C$38.12 million in the same quarter a year ago.

The firm’s net loss widened to C$127.14 million during the quarter compared to a net loss of C$38.12 million in the same quarter a year ago. On the positive side, however, the company said it has entered into an amendment to its credit agreement with all of the lenders to its senior secured term loan

Stocktwits sentiment suggests investors are optimistic about McDonald’s prospects, but lack confidence in Tilray Brands and Beyond Inc.’s ability to deliver strong earnings results on Monday.1. Tilray Brands Inc: According to a Street estimate, the cannabis-lifestyle and consumer packaged goods is expected to announce earnings per share (EPS) of (-$0.01) and revenue of $226.94 million when it reports pre-market on Monday. Retail investors have turned cautious on the stock ahead of the announcement with the sentiment meter dipping into neutral territory (54/100) from the bullish zone a day earlier.<figure class="image"><a href="https://stocktwits.com/symbol/TLRY"><img style="aspect-ratio:1578/450;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_07_26_at_10_18_09_AM_9ef7e56d7b.png" alt="Retail sentiment trends in neutral territory for Tilray Brands ahead of earnings" width="1578" height="450"></a><figcaption>Retail sentiment trends in the neutral territory for Tilray Brands ahead of earnings</figcaption></figure>Recently, the firm’s Germany cannabis cultivation facility, Aphria RX GmbH received the first new cannabis cultivation license issued under MedCanG, Germany’s new Cannabis Act. This allows Aphria RX to cultivate and manufacture a broad commercial range of medical cannabis.&nbsp;However, retail investors remain concerned about the uncertainty around cannabis policies in the backdrop of US elections. Both Kamala Harris and Donald Trump are reportedly known to have displayed mixed stances on cannabis, leading to investor concern about what could materialize once the elections are over.2. Beyond Inc: The online retailer, which owns Overstock, Bed Bath &amp; Beyond, and Zulily, is expected to report second quarter EPS at (-$0.83) and revenue at $382 million after the bell on Monday. Retail investor sentiment recently dipped into bearish territory (42/100) after spending much of the previous month in a bullish zone.Recently, the company said it has reopened Overstock.com, which now has an inventory lineup that includes closeouts, liquidation, factory direct, and reverse logistics merchandise. The management said it is encouraged by accelerating revenue run-rate in the first 90 days.Despite the positive news, retail investors appear to be maintaining caution on the stock as the firm has recently announced structural leadership changes, eliminating the co-Chief Executive roles and the dual chief merchant roles. Investors are trying to understand the impact of these changes in the firm’s earnings before changing their view.3. McDonald's Corp: The fast food chain will report its second quarter results on Monday before the opening bell. According to a Street estimate, the firm is expected to post EPS of $3.08 on revenues of $6.63 billion. Some analysts anticipate its results and guidance will be impacted by the effects of inflation on consumer spending patterns.On the positive side, however, the firm is expected to make a recovery toward the second half of the year following its value meal introduction. Management remains enthusiastic about the potential increase in foot traffic due to this initiative, with 93% of its franchisees opting to extend the promotion through the end of August. Retail agrees with the optimistic take as well, with Stocktwits sentiment in bullish territory (61/100) supported by high message volume.<figure class="image"><a href="https://stocktwits.com/symbol/MCD"><img style="aspect-ratio:1582/458;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_07_26_at_10_21_01_AM_c7f4b0dfbf.png" alt="Retail sentiment trends in bullish territory for McDonald's Corp" width="1582" height="458"></a><figcaption>Retail sentiment trends in the bullish territory for McDonald's Corp</figcaption></figure>Photo Courtesy: Jurij Kenda on Unsplash

Earnings Preview: Tilray Brands, Beyond Inc. and McDonald’s Report Monday — What Retail Is Thinking

Retail investors are bullish on McDonald’s Corp., but less enthusiastic about Tilray Brands and Beyond Inc.

Retail investors are bullish on McDonald’s Corp., but less enthusiastic about Tilray Brands and Beyond Inc. ahead of earnings.

Amplify ETF Trust - Amplify Alternative Harvest ETF

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

Ahead of earnings, sentiment is split between blowout AI growth and concerns around macro pressure, positioning, and post-ER volatility. How do you see it playing out?

MJ
Amplify Alternative Harvest ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest MJ News

MJAmplify Alternative Harvest ETF